A Safety Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Painful Diabetic Neuropathy
Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
Study CLO-311 is a multicenter, open-label, single-arm study to assess the long-term use of
Clonidine Gel in the treatment of pain associated with PDN. Subjects who have completed their
12-week participation in Study CLO-290 or Study CLO-310 are eligible to rollover into this
study and receive active study drug in an open-label manner.